What you need to know before Medibank Private Ltd reports on Friday

Medibank Private Ltd (ASX:MPL) will report its interim results tomorrow in what will be one of the most highly anticipated reports this earnings season.

| More on:
a woman

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

Medibank Private Ltd (ASX: MPL) will announce its interim results to the market on Friday, 20 February, in what will be one of the most highly anticipated reports this earnings season.

Although it listed on the ASX less than three months ago, retail investors who bought shares in the float are already sitting on a 27% paper profit. The shares closed at $2.54 on Wednesday after reaching a new all-time high of $2.57 earlier in the session.

At that price however, the stock is trading on a price-earnings ratio of 27.2x last year's earnings. With many analysts concerned about how much the stock has risen, investors will be looking for reasons to justify its rather lofty price. Here are some of the things you need to be aware of before Medibank Private reports tomorrow…

Costs. Investors will be looking out for cost reductions which have hindered Medibank Private's earnings in years gone past.

Margins. Medibank Private will need to improve its margins to become more competitive. Its net underwriting margin has averaged 4.5% over the last three years, significantly lagging behind the margins recorded by rivals such as BUPA and NIB Holdings Limited (ASX: NHF).

Earnings. The insurer forecast earnings growth of 6% this financial year, indicating earnings per share of 9.4 cents. Given the stock's valuation, investors will likely be looking out for a revised earnings guidance.

Core business. Medibank Private has a much larger and more aggressive investment portfolio than most other insurers, and relies on this to drive profit growth. While the company should benefit from the market's recent strength, investors should ensure strong growth is also being recorded in Medibank's core business.

Dividends. Investors should not expect a dividend to be announced. As outlined in Medibank Private's prospectus, it expects to pay its first dividend in September 2015, equating to 4.9 cents per share (fully franked). That gives the stock an expected 1.9% dividend yield.

Medibank is a good company but, at today's price, would be best left on your watchlist. Until the company is able to justify its lofty valuation, there's another stock which could be a much (much) better buy today.

Introducing: The Motley Fool's top stock pick for 2015 – Yours FREE!

Motley Fool contributor Ryan Newman does not own shares in any of the companies mentioned. You can follow Ryan on Twitter @ASXvalueinvest.

More on ⏸️ Investing

Close up of baby looking puzzled
Retail Shares

What has happened to the Baby Bunting (ASX:BBN) share price this year?

It's been a volatile year so far for the Aussie nursery retailer. We take a closer look

Read more »

woman holds sign saying 'we need change' at climate change protest
ETFs

3 ASX ETFs that invest in companies fighting climate change

If you want to shift some of your investments into more ethical companies, exchange-traded funds can offer a good option

Read more »

a jewellery store attendant stands at a cabinet displaying opulent necklaces and earrings featuring diamonds and precious stones.
⏸️ Investing

The Michael Hill (ASX: MHJ) share price poised for growth

Investors will be keeping an eye on the Michael Hill International Limited (ASX: MHJ) share price today. The keen interest…

Read more »

ASX shares buy unstoppable asx share price represented by man in superman cape pointing skyward
⏸️ Investing

The Atomos (ASX:AMS) share price is up 15% in a week

The Atomos (ASX: AMS) share price has surged 15% this week. Let's look at what's ahead as the company build…

Read more »

Two people in suits arm wrestle on a black and white chess board.
Retail Shares

How does the Temple & Webster (ASX:TPW) share price stack up against Nick Scali (ASX:NCK)?

How does the Temple & Webster (ASX: TPW) share price stack up against rival furniture retailer Nick Scali Limited (ASX:…

Read more »

A medical researcher works on a bichip, indicating share price movement in ASX tech companies
Healthcare Shares

The Aroa (ASX:ARX) share price has surged 60% since its IPO

The Aroa (ASX:ARX) share price has surged 60% since the Polynovo (ASX: PNV) competitor listed on the ASX in July.…

Read more »

asx investor daydreaming about US shares
⏸️ How to Invest

How to buy US shares from Australia right now

If you have been wondering how to buy US shares from Australia to gain exposure from the highly topical market,…

Read more »

⏸️ Investing

Why Fox (NASDAQ:FOX) might hurt News Corp (ASX:NWS) shareholders

News Corporation (ASX: NWS) might be facing some existential threats from its American cousins over the riots on 6 January

Read more »